{"id":"https://openalex.org/W7220909665","doi":"https://doi.org/10.25405/ncl.34200564","title":"Substituted 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidines Are Highly Active CDK9 Inhibitors: Synthesis, X-ray Crystal Structures, Structure-Activity Relationship, and Anticancer Activities","display_name":"Substituted 4-(Thiazol-5-yl)-2-(phenylamino)pyrimidines Are Highly Active CDK9 Inhibitors: Synthesis, X-ray Crystal Structures, Structure-Activity Relationship, and Anticancer Activities","publication_year":2013,"publication_date":"2013-01-09","ids":{"openalex":"https://openalex.org/W7220909665","doi":"https://doi.org/10.25405/ncl.34200564"},"language":"en","primary_location":{"id":"doi:10.25405/ncl.34200564","doi":"https://doi.org/10.25405/ncl.34200564","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34200564","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.25405/ncl.34200564","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5125298905","display_name":"Hao Shao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hao Shao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102077985","display_name":"Shenhua Shi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shenhua Shi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080636240","display_name":"\u9ec4\u4e16\u4eae","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shiliang Huang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001367842","display_name":"Alison J. Hole","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alison J. Hole","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112345244","display_name":"Abdullahi Yahya Abbas","orcid":"https://orcid.org/0000-0001-7466-721X","observed_orcids":["https://orcid.org/0000-0001-7466-721X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abdullahi Y. Abbas","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073309765","display_name":"Sonja Baumli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sonja Baumli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078387716","display_name":"Xiangrui Liu","orcid":"https://orcid.org/0000-0003-4960-5847","observed_orcids":["https://orcid.org/0000-0003-4960-5847"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiangrui Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104304216","display_name":"Frankie Lam","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frankie Lam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087663058","display_name":"David Foley","orcid":"https://orcid.org/0000-0001-8449-4754","observed_orcids":["https://orcid.org/0000-0001-8449-4754"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David W. Foley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041852883","display_name":"Peter M. Fischer","orcid":"https://orcid.org/0000-0002-5866-9271","observed_orcids":["https://orcid.org/0000-0002-5866-9271"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter M. Fischer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078994565","display_name":"Martin E. M. Noble","orcid":"https://orcid.org/0000-0002-3595-9807","observed_orcids":["https://orcid.org/0000-0002-3595-9807"]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Martin Noble","raw_affiliation_strings":["Newcastle University"],"raw_orcid":"https://orcid.org/0000-0002-3595-9807","affiliations":[{"raw_affiliation_string":"Newcastle University","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061437207","display_name":"Jane Endicott","orcid":"https://orcid.org/0000-0003-4868-0116","observed_orcids":["https://orcid.org/0000-0003-4868-0116"]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jane Endicott","raw_affiliation_strings":["Newcastle University"],"raw_orcid":"https://orcid.org/0000-0003-4868-0116","affiliations":[{"raw_affiliation_string":"Newcastle University","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054060709","display_name":"Chris J. Pepper","orcid":"https://orcid.org/0000-0003-3603-8839","observed_orcids":["https://orcid.org/0000-0003-3603-8839"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chris Pepper","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5147752434","display_name":"Shudong Wang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shudong Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cdk9-inhibitor","display_name":"CDK9 inhibitor","score":0.9909999966621399},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.7850000262260437},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.6769999861717224},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9860000014305115},{"id":"https://openalex.org/keywords/protein-ligand-binding-mode","display_name":"protein-ligand binding mode","score":0.6940000057220459},{"id":"https://openalex.org/keywords/apoptosis-induction","display_name":"apoptosis induction","score":0.5329999923706055},{"id":"https://openalex.org/keywords/x-ray-crystal-structure","display_name":"X-ray crystal structure","score":0.6069999933242798},{"id":"https://openalex.org/keywords/small-molecule-kinase-inhibitors","display_name":"small-molecule kinase inhibitors","score":0.5789999961853027}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5928000211715698},{"id":"https://openalex.org/C2776568683","wikidata":"https://www.wikidata.org/wiki/Q23005640","display_name":"Moiety","level":2,"score":0.5282999873161316},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.5189999938011169},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.49559998512268066},{"id":"https://openalex.org/C2779321679","wikidata":"https://www.wikidata.org/wiki/Q207722","display_name":"Pyrimidine","level":2,"score":0.4722000062465668},{"id":"https://openalex.org/C59143045","wikidata":"https://www.wikidata.org/wiki/Q15314942","display_name":"Cyclin-dependent kinase 9","level":5,"score":0.4339999854564667},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4147999882698059},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4065999984741211},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.39629998803138733},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.3682999908924103},{"id":"https://openalex.org/C118792377","wikidata":"https://www.wikidata.org/wiki/Q108584245","display_name":"Selectivity","level":3,"score":0.3472000062465668},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.33880001306533813},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3239000141620636},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.31529998779296875},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.3138999938964844},{"id":"https://openalex.org/C171122931","wikidata":"https://www.wikidata.org/wiki/Q6324626","display_name":"K562 cells","level":3,"score":0.3046000003814697},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.3025999963283539},{"id":"https://openalex.org/C174510640","wikidata":"https://www.wikidata.org/wiki/Q489618","display_name":"HEK 293 cells","level":3,"score":0.2957000136375427},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.29429998993873596},{"id":"https://openalex.org/C41183919","wikidata":"https://www.wikidata.org/wiki/Q423026","display_name":"Active site","level":3,"score":0.2935999929904938},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.2930999994277954},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2930000126361847},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.29109999537467957},{"id":"https://openalex.org/C11804247","wikidata":"https://www.wikidata.org/wiki/Q896177","display_name":"Protein\u2013protein interaction","level":2,"score":0.2849999964237213},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.27309998869895935},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.27059999108314514},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2678999900817871},{"id":"https://openalex.org/C2780120296","wikidata":"https://www.wikidata.org/wiki/Q96286","display_name":"Hydrolase","level":3,"score":0.2621000111103058},{"id":"https://openalex.org/C2776591724","wikidata":"https://www.wikidata.org/wiki/Q5459651","display_name":"Flip","level":3,"score":0.2590000033378601},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2556999921798706},{"id":"https://openalex.org/C46622094","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic window","level":2,"score":0.25360000133514404},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.2517000138759613},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.2515000104904175}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.25405/ncl.34200564","doi":"https://doi.org/10.25405/ncl.34200564","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34200564","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.25405/ncl.34200564.v1","doi":"https://doi.org/10.25405/ncl.34200564.v1","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34200564.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.25405/ncl.34200564","doi":"https://doi.org/10.25405/ncl.34200564","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34200564","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4308348117","https://openalex.org/W2001971400","https://openalex.org/W1976189767","https://openalex.org/W7009183073","https://openalex.org/W3127215652","https://openalex.org/W1150311174","https://openalex.org/W4411302141","https://openalex.org/W2016365699","https://openalex.org/W4309371653","https://openalex.org/W4296880345"],"abstract_inverted_index":{"Cancer":[0],"cells":[1,135],"often":[2],"have":[3],"a":[4,31,115,119,137],"high":[5],"demand":[6],"for":[7,79,121],"antiapoptotic":[8],"proteins":[9,22],"in":[10,26,108,114],"order":[11],"to":[12,40,47,89],"resist":[13],"programmed":[14],"cell":[15],"death.":[16],"CDK9":[17,56,68,80,90],"inhibition":[18],"selectively":[19],"targets":[20],"survival":[21],"and":[23,51,58,74,91,141],"reinstates":[24],"apoptosis":[25],"cancer":[27],"cells.":[28],"We":[29],"designed":[30],"series":[32],"of":[33,43,61,86,105,145],"4-thiazol-2-anilinopyrimidine":[34],"derivatives":[35],"with":[36,69,102,110,136],"functional":[37],"groups":[38],"attached":[39],"the":[41,44,48,62,96,122],"CS-position":[42],"pyrimidine":[45],"or":[46],"C4-thiazol":[49],"moiety":[50],"investigated":[52],"their":[53],"effects":[54],"on":[55],"potency":[57],"selectivity.":[59],"One":[60],"most":[63],"selective":[64],"compounds,":[65],"12u":[66,87,125],"inhibits":[67],"IC50":[70],"=":[71],"7":[72],"nM":[73],"shows":[75],"over":[76,143],"80-fold":[77],"selectivity":[78],"versus":[81],"CDK2.":[82],"X-ray":[83],"crystal":[84,103],"structures":[85,104],"bound":[88],"CDK2":[92],"provide":[93],"insights":[94],"into":[95],"binding":[97],"modes.":[98],"This":[99],"work,":[100],"together":[101],"selected":[106],"inhibitors":[107],"complex":[109],"both":[111],"enzymes":[112],"described":[113],"companion":[116],"paper,(34)":[117],"provides":[118],"rationale":[120],"observed":[123],"SAR.":[124],"demonstrates":[126],"potent":[127],"anticancer":[128],"activity":[129],"against":[130],"primary":[131],"chronic":[132],"lymphocytic":[133],"leukemia":[134],"therapeutic":[138],"window":[139],"31-":[140],"107-fold":[142],"those":[144],"normal":[146],"B-and":[147],"T-cells.":[148]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-09T00:00:00"}